GILEAD SCIENCES DL-,001 | 54.060 / -1.89% |
Date/Time | 01/27 / 15:10 |
Chg. / Chg.(%) | -1.040 / -1.89% |
Bid | 53.930 / 190 |
Ask | 54.050 / 190 |
Open | 54.590 |
Previous Close | 55.100 |
High | 54.990 |
Low | 54.040 |
Volume [EUR] | 650,215.190 |
Volume [Units] | 11,922 |
Price fixings | 128 |
ISIN | US3755581036 |
Security | GIS |
Exchange | TradeGate |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
TradeGate | 54.060 | ![]() |
11,922 |
Xetra | 54.45 | ![]() |
7,340 |
Frankfurt | 54.6400 | ![]() |
1,491 |
München | 54.45 | ![]() |
758 |
Stuttgart | 54.230 | ![]() |
691 |
gettex | 54.360 | ![]() |
665 |
Vienna Globa.. | 54.20 | ![]() |
615 |
Borsa Italia.. | 54.33 | ![]() |
523 |
Hamburg | 54.20 | ![]() |
115 |
Hannover | 54.60 | ![]() |
100 |
Berlin | 54.58 | ![]() |
0 |
Düsseldorf | 54.10 | ![]() |
0 |
Lang & Schwa.. | 54.150 | ![]() |
|
NASDAQ | 66.7000 | ![]() |
7,125,214 |
Cboe US | 66.69 | 561,682 | |
IEX | 66.70 | ![]() |
352,106 |
London Inter.. | 67.69 | 6,663 | |
Mexico | 1,333.00 | ![]() |
146 |
Borsa Italia.. | 54.71 | ![]() |
20 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Jounce Therapeutics Announces Initiation of Phase 1 INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and PD-1 Inhibitor Combination Therapy in Patients with Advanced Solid Tumors
01/13/2021 / 14:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - Remdesivir could work against new COVID strains - Gilead
01/11/2021 / 15:21 - TeleTrader - Intercept Appoints Jared M. Freedberg as General Counsel and Secretary
01/11/2021 / 14:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
